Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients: A meta-analysis

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 9, 2010, Pages 1128-1133

  Rokkas, Theodore ^a   Sechopoulos, Panos ^a   Pistiolas, Dimitrios ^a   Margantinis, Georgios ^a   Koukoulis, Georgios ^a  

^a HENRY DUNANT HOSPITAL   (Greece)

Author keywords

first degree relatives; gastric cancer; increased risk; meta analysis

Indexed keywords

ARTICLE; ATROPHY; CANCER CONTROL; CANCER PATIENT; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; INTESTINE METAPLASIA; MEDICAL LITERATURE; META ANALYSIS; NONHUMAN; PRECANCER; PREVALENCE; PRIORITY JOURNAL; STOMACH CANCER; SYSTEMATIC REVIEW;

FAMILY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PRECANCEROUS CONDITIONS; PREVALENCE; RISK FACTORS; STOMACH NEOPLASMS;

EID: 77955466167     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283398d37     Document Type: Article

References (40)

1. Alberts SR, Cervantes A, van De Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 2003; 14 (Suppl 2):ii31-ii36.
2. Jemal A, Siegel R,Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58:71-96.
3. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49.
4. Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000.
5. Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, Senz J, Grehan N, et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004; 41:508-517.
6. Milne AN, Carneiro F, O'Morain C, Offerhaus GJA. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet 2009; 126:615-628.
7. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52:6735-6740.
8. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst 1959; 22:719-748.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188.
10. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 8:101-129.
11. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539-1558.
12. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F, editors. In: Methods for meta-analysis in medical research. New York: John Wiley & Sons, Ltd; 2000.
13. Copas JB, Shi JQ. A sensitivity analysis for publication bias in systematic reviews. Stat Methods Med Res 2001; 10:251-265.
14. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. Br Med J 1997; 315:29-34.
15. Carneiro F, Taveira-Gomes A, Cabral-Correia A, Vasconcelos-Teixeira A, Barreira R, Cardoso-Oliveira M, Sobrinho-Simõ es M. Characteristics of the gastric mucosa of direct relatives of patients with sporadic gastric carcinoma. Eur J Cancer Prev 1993; 2:239-246.
16. Meining AG, Bayerdö rffer E, Stolte M. Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients. Eur J Gastroenterol Hepatol 1999; 11:717-720.
17. Brenner H, Bode G, Boeing H. Helicobacter pylori infection among offspring of patients with stomach cancer. Gastroenterology 2000; 118:31-35.
18. El-Omar EM, Oien K, Murray LS, El-Nujumi A, Wirz A, Gillen D, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000; 118:22-30.
19. Jablonská M, Chlumská A. Genetic factors in the development of gastric precancerous lesions-a role of Helicobacter pylori? J Physiol Paris 2001; 95:477-481.
20. Chang YW, Han YS, Lee DK, Kim HJ, Lim HS, Moon JS, et al. Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients. Int J Cancer 2002; 101:469-474.
21. Sheu BS, Yang HB, Sheu SM, Huang AH, Wu JJ. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients. Clin Cancer Res 2003; 9:5245-5251.
22. Romiti A, Zullo A, Tomao S, Hassan C, Sarcina I, De Francesco V, et al. Gastric mucosa alterations in first-degree relatives of gastric cancer patients. Anticancer Res 2005; 25:2567-2572.
23. Leung WK, Ng EK, Lam CC, Chan KF, Chan WY, Auyeung AC, et al. Helicobacter pylori infection in 1st degree relatives of Chinese gastric cancer patients. Scand J Gastroenterol 2006; 41:274-279.
24. Motta CR, Cunha MP, Queiroz DM, Cruz FW, Guerra EJ, Mota RM, Braga LL, Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil. Digestion 2008; 78:3-8.
25. Shin CM, Kim N, Yang HJ, Cho SI, Lee HS, Kim JS, et al. Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer. J Clin Gastroenterol 2010; 44:e34-e39.
26. Williams MP, Pounder RE. Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol 1999; 94:S11-S16.
27. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341:1359-1362.
28. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114:1169-1179.
29. Eslick GD, Lim LLY, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999; 94:2373-2379.
30. International Agency for Research on Cancer (IARC), Lion, France. Monographs on the evaluation of the carcinogenic risks to humans. Schistosomes, Liver Flukes and Helicobacter pylori 1994; 61:177-241.
31. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333:32-41.
32. La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer 1992; 70:50-55.
33. Palli D, Galli M, Caporaso NE, Cipriani F, Decarli A, Saieva C, et al. Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev 1994; 3:15-18.
34. Brenner H, Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G, et al. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer 2000; 88:274-279.
35. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56:772-781.
36. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291:187-194.
37. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 2007; 12 (Suppl 2):32-38.
38. Kim N, Park RY, Cho SI, Lim SH, Lee KH, Lee W, et al. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up. J Clin Gastroenterol 2008; 42:448-454.
39. Kim N, Park YS, Cho SI, Lee HS, Choe G, Kim IW, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease. Helicobacter 2008; 13:245-255.
40. Liu CY,Wu CY, Lin JT, Lee YC, Yen AM, Chen TH, et al. Multistate and multifactorial progression of gastric cancer: results from community-based mass screening for gastric cancer. J Med Screen 2006; 13 (Suppl 1):S2-S5.